MedTrace Logo

Assessment of Body Composition, Fatigue, Mobility and Functional Status in Post-Stroke Individuals

NCT06255145 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2024-02-13

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to evaluate body composition, fatigue, mobility level, functional status in with stroke individuals. The main questions it aims to answer are:

How is body composition affected in individuals with stroke? How is the level of fatigue affected in individuals with stroke? How is the mobility level affected in individuals with stroke? How is functional status affected in individuals with stroke? In this study, we included 21 patients with stroke and 21 healthy controls. The body composition of the participants was evaluated by Bioelectrical Impedance Analysis (BIA), fatigue level by Fatigue Severity Scale (FSS), mobility level by Rivermead Mobility Index (RMI), and functional status by Functional Independence Scale (FIM).

Conditions

  • Cerebrovascular Stroke
  • Body Composition

Interventions

DEVICE

Bioelectrical Impedance Analysis

Bioelectrical Impedance Analysis Beurer BF 1000 Super Precision device was used to measure the body composition of the participants. Operating on the principle of BIA, the device allows the body composition to be evaluated by giving an imperceptible electric current to the body. Fatigue Severity Scale (FSS) Fatigue Severity Scale (FSS) was used to measure participants' fatigue levels. Rivermead Mobility Index Rivermead Mobility Index (RMI) was used to assess the mobility levels of the participants. Functional Independence Measure Functional Independence Measure (FIM) was used to evaluate the functional status of the participants.

Sponsors & Collaborators

  • Pamukkale University

    lead OTHER

Principal Investigators

  • Raziye Çelik, PT. · Pamukkale University

  • Emre Baskan, Assoc Prof. · Pamukkale University

  • Aziz Dengiz, PT Phd · Muş Alparslan University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-17
Primary Completion
2022-06-05
Completion
2022-07-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06255145 on ClinicalTrials.gov